Adinei Abadio Soares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adinei Abadio Soares has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Débora Tavares de Resendee Silva
Graduate Program in Biomedical Sciences, Federal University of Fronteira Sul (UFFS), Chapecó, Brazil
6 shared publications - Kailane Paula Pretto
Department of Nursing, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil
4 shared publications - Bernardo Ribeiro Böhm
Department of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil
2 shared publications - Bruna Dias de Oliveira
Department of Nursing, Federal University of Fronteira Sul (UFFS), Chapecó, Brazil
2 shared publications - Camila Ferreira Puntel
Universidade Federal da Fronteira Sul
2 shared publications - Letícia de Souza Matias
Graduate Program in Biomedical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1)
Adenosine Signaling in Primary and Metastatic Brain Tumors: Immune Suppression, Tumor Progression, and Therapeutic Opportunities
Brain tumors, whether primary or metastatic, remain a significant cause of cancer-related mortality and are characterized by a profoundly immunosuppressive tumor microenvironment (TME). Among the signaling pathways that shape this environment, purinergic signaling—particularly the adenosine (ADO) axis—has emerged as a central regulator of tumor progression. In the TME, extracellular ATP (eATP) is sequentially converted into ADO by the ectonucleotidases CD39 and CD73, leading to sustained activation of adenosine P1 receptors. This review examines the receptor-specific roles of A1, A2A, A2B, and A3 receptors in modulating neuroinflammation, immune evasion, and therapeutic resistance across distinct brain tumor entities. At low extracellular ADO concentrations, high-affinity A1 and A2A receptors dominate signaling; A1 receptor (A1R) activation predominantly exerts neuroprotective effects by limiting glutamatergic excitotoxicity and preserving blood–brain barrier (BBB) integrity. However, under pathological conditions characterized by sustained ADO accumulation, this homeostatic balance is disrupted. Elevated ADO levels progressively engage low-affinity A2B and A3 receptors, while prolonged A2A receptor activation shifts from regulatory to immunosuppressive signaling, collectively driving T-cell dysfunction, angiogenesis, glioblastoma stem-like cell maintenance, and metastatic competence. Taken together, these findings highlight that pathological ADO receptor engagement in brain tumors is governed by extracellular ADO availability and receptor affinity, supporting a pharmacological framework in which selective inhibition of A2B and A3 receptors, combined with context-dependent modulation of A2A and preservation of A1R-mediated neuroprotective signaling, represents a rational strategy to limit tumor progression while minimizing adverse neurological effects.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1)
Open AccessAdenosine Signaling in Primary and Metastatic Brain Tumors: Immune Suppression, Tumor Progression, and Therapeutic Opportunities
Brain tumors, whether primary or metastatic, remain a significant cause of cancer-related mortality and are characterized by a profoundly immunosuppressive tumor microenvironment (TME). Among the signaling pathways that shape this environment, purinergic signaling—particularly the adenosine (ADO) axis—has emerged as a central regulator of tumor progression. In the TME, extracellular ATP (eATP) is sequentially converted into ADO by the ectonucleotidases CD39 and CD73, leading to sustained activation of adenosine P1 receptors. This review examines the receptor-specific roles of A1, A2A, A2B, and A3 receptors in modulating neuroinflammation, immune evasion, and therapeutic resistance across distinct brain tumor entities. At low extracellular ADO concentrations, high-affinity A1 and A2A receptors dominate signaling; A1 receptor (A1R) activation predominantly exerts neuroprotective effects by limiting glutamatergic excitotoxicity and preserving blood–brain barrier (BBB) integrity. However, under pathological conditions characterized by sustained ADO accumulation, this homeostatic balance is disrupted. Elevated ADO levels progressively engage low-affinity A2B and A3 receptors, while prolonged A2A receptor activation shifts from regulatory to immunosuppressive signaling, collectively driving T-cell dysfunction, angiogenesis, glioblastoma stem-like cell maintenance, and metastatic competence. Taken together, these findings highlight that pathological ADO receptor engagement in brain tumors is governed by extracellular ADO availability and receptor affinity, supporting a pharmacological framework in which selective inhibition of A2B and A3 receptors, combined with context-dependent modulation of A2A and preservation of A1R-mediated neuroprotective signaling, represents a rational strategy to limit tumor progression while minimizing adverse neurological effects.
- Open Access
- 30 July 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1113-1114
Correction to: The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia
- 30 July 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1113-1114
Open AccessCorrection to: The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia
- 4 July 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1103-1111
The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia
Endometriosis is a chronic gynecological condition characterized by endometrial tissue outside the uterine cavity. Recent research has focused on the relationship between the purinergic system and endometriosis. As a purinergic system component, extracellular adenosine triphosphate (ATP) has been involved as a crucial mediator of chronic pain associated with the disease, as well as P2X3 receptors, which play a key role in sensitization of nerve fibers and generation of nociceptive, neuropathic, and inflammatory pain. In addition, ectonucleotidases such as CD39 and CD73, which regulate ATP hydrolysis, have an altered expression in endometriotic lesions, contributing to extracellular ATP accumulation, intensifying inflammation and pain. Together, immune cells and their product are increased in endometriotic foci and promote the emergence of new lesions through their contribution to retrograde menstruation. Some studies have observed significant changes in mitochondrial respiration, notably decreased oxygen consumption in the affected endometrium. These various cellular processes that are mediated by ATP and adenosine in the uterine cavity and exert effects on immune defense will be herein reviewed in detail to investigate possible inhibitors, their activity, and potential exploration of the purinergic pathway as a therapeutic alternative. Graphical abstract
- 4 July 2025
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (5) , 1103-1111
The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia
Endometriosis is a chronic gynecological condition characterized by endometrial tissue outside the uterine cavity. Recent research has focused on the relationship between the purinergic system and endometriosis. As a purinergic system component, extracellular adenosine triphosphate (ATP) has been involved as a crucial mediator of chronic pain associated with the disease, as well as P2X3 receptors, which play a key role in sensitization of nerve fibers and generation of nociceptive, neuropathic, and inflammatory pain. In addition, ectonucleotidases such as CD39 and CD73, which regulate ATP hydrolysis, have an altered expression in endometriotic lesions, contributing to extracellular ATP accumulation, intensifying inflammation and pain. Together, immune cells and their product are increased in endometriotic foci and promote the emergence of new lesions through their contribution to retrograde menstruation. Some studies have observed significant changes in mitochondrial respiration, notably decreased oxygen consumption in the affected endometrium. These various cellular processes that are mediated by ATP and adenosine in the uterine cavity and exert effects on immune defense will be herein reviewed in detail to investigate possible inhibitors, their activity, and potential exploration of the purinergic pathway as a therapeutic alternative. Graphical abstract
- 28 March 2025
- Published by Springer Nature in Inflammation Research
- Vol. 74 (1) , 1-10
Inflammatory pain and electroacupuncture: how the P2X3 receptor can help modulate inflammation—a review of current literature
Aim Inflammatory pain arises from tissue stress or injury and is initiated by signaling molecules that stimulate the immune and nervous systems. Evidence suggests that purinergic signaling pathways can modulate pain and inflammation through the activation of P1 and P2 purinergic receptors, such as the P2X3 receptor, which are stimulated by extracellular molecules like adenosine triphosphate (ATP). Electroacupuncture (EA) exhibits precise mechanisms that modulate inflammatory pain through the activation of the P2X3 receptor. Objective This review analyzed evidence regarding the role of electroacupuncture and the purinergic system, particularly the P2X3 receptor, in modulating inflammation and pain. Materials and methods A search for the most relevant articles available in the SciVerse Scopus and MEDLINE/PubMed databases was conducted for publications from 1995 to 2024. Articles were initially selected by reading the title, abstract, and main text, respectively. Results It was found that the P2X3 receptor, as well as the molecules activating purinergic receptors, such as ATP and adenosine, have the potential to regulate pain and inflammation. Additionally, EA can modulate the purinergic system in an anti-inflammatory response. EA may stimulate analgesia mainly through the conversion of ATP to adenosine, a crucial molecule in pain control. Conclusion The purinergic system directly influences inflammatory pain and controls inflammation. In this context, EA has the potential to orchestrate this system to control pain and inflammation.
- 28 March 2025
- Published by Springer Nature in Inflammation Research
- Vol. 74 (1) , 1-10
Inflammatory pain and electroacupuncture: how the P2X3 receptor can help modulate inflammation—a review of current literature
Aim Inflammatory pain arises from tissue stress or injury and is initiated by signaling molecules that stimulate the immune and nervous systems. Evidence suggests that purinergic signaling pathways can modulate pain and inflammation through the activation of P1 and P2 purinergic receptors, such as the P2X3 receptor, which are stimulated by extracellular molecules like adenosine triphosphate (ATP). Electroacupuncture (EA) exhibits precise mechanisms that modulate inflammatory pain through the activation of the P2X3 receptor. Objective This review analyzed evidence regarding the role of electroacupuncture and the purinergic system, particularly the P2X3 receptor, in modulating inflammation and pain. Materials and methods A search for the most relevant articles available in the SciVerse Scopus and MEDLINE/PubMed databases was conducted for publications from 1995 to 2024. Articles were initially selected by reading the title, abstract, and main text, respectively. Results It was found that the P2X3 receptor, as well as the molecules activating purinergic receptors, such as ATP and adenosine, have the potential to regulate pain and inflammation. Additionally, EA can modulate the purinergic system in an anti-inflammatory response. EA may stimulate analgesia mainly through the conversion of ATP to adenosine, a crucial molecule in pain control. Conclusion The purinergic system directly influences inflammatory pain and controls inflammation. In this context, EA has the potential to orchestrate this system to control pain and inflammation.
- Open Access
- 1 October 2024
- Published by Universidad Nacional de La Plata in Educación Física y Ciencia
- Vol. 26 (4) , e318
Aptidão funcional e física de idosos: influência do programa “mexa-se” da academia da saúde
Com o envelhecimento, ocorre um processo natural de declínio funcional no corpo humano, mas, ao mesmo tempo, sabe-se que o estilo de vida influencia diretamente sobre a velocidade e intensidade deste processo. A atividade física tem relação direta com a qualidade de vida do ser humano pois é capaz de amenizar os efeitos degenerativos provocados pela senescência através da sua ação sobre o corpo e mente. O presente artigo teve como objetivo avaliar e comparar a aptidão funcional de um grupo de idosos participantes de um programa de exercícios físicos semanal “Mexa-se” da Academia da Saúde do município de Flor do Sertão- SC. O estudo buscou verificar variáveis e informações sobre aptidão funcional. Para a amostra, foi realizada a seleção de 30 idosos de forma intencional e com participação voluntária. Os idosos foram divididos em dois grupos: o Grupo Mexa-se, composto por 15 idosos que frequentam regularmente o programa da Academia da Saúde e o Grupo Controle, composto por 15 idosos que não frequentam. O desempenho do Grupo Mexa- se foi melhor significativamente para as variáveis flexibilidade (p=0,050), força de preensão manual de membro esquerdo (p=0,031) e resistência cardiorrespiratória (p=0,043). Conclui-se através do presente trabalho que a realização frequente de atividade física influencia diretamente sobre a aptidão funcional de idosos. A prática do exercício físico na terceira idade proporciona um envelhecimento com melhor qualidade de vida, bem-estar e independência.
- 1 October 2024
- Published by Universidad Nacional de La Plata in Educación Física y Ciencia
- Vol. 26 (4) , e318
Open AccessAptidão funcional e física de idosos: influência do programa “mexa-se” da academia da saúde
Com o envelhecimento, ocorre um processo natural de declínio funcional no corpo humano, mas, ao mesmo tempo, sabe-se que o estilo de vida influencia diretamente sobre a velocidade e intensidade deste processo. A atividade física tem relação direta com a qualidade de vida do ser humano pois é capaz de amenizar os efeitos degenerativos provocados pela senescência através da sua ação sobre o corpo e mente. O presente artigo teve como objetivo avaliar e comparar a aptidão funcional de um grupo de idosos participantes de um programa de exercícios físicos semanal “Mexa-se” da Academia da Saúde do município de Flor do Sertão- SC. O estudo buscou verificar variáveis e informações sobre aptidão funcional. Para a amostra, foi realizada a seleção de 30 idosos de forma intencional e com participação voluntária. Os idosos foram divididos em dois grupos: o Grupo Mexa-se, composto por 15 idosos que frequentam regularmente o programa da Academia da Saúde e o Grupo Controle, composto por 15 idosos que não frequentam. O desempenho do Grupo Mexa- se foi melhor significativamente para as variáveis flexibilidade (p=0,050), força de preensão manual de membro esquerdo (p=0,031) e resistência cardiorrespiratória (p=0,043). Conclui-se através do presente trabalho que a realização frequente de atividade física influencia diretamente sobre a aptidão funcional de idosos. A prática do exercício físico na terceira idade proporciona um envelhecimento com melhor qualidade de vida, bem-estar e independência.
- 1 October 2024
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (3) , 429-446
Purines and purinergic receptors in primary tumors of the central nervous system
Purine nucleotides and nucleosides play critical roles in various pathological conditions, including tumor cell growth. Adenosine triphosphate (ATP) activates pro-tumor receptors, while adenosine (ADO) is a potent immunosuppressant and modulator of cell growth. This study aims to analyze the purinergic actions of ATP and its metabolites, associated enzymes, and P1 or P2 class receptors in primary central nervous system tumors. Additionally, we sought to correlate the levels of nucleosides and the density of P1, P2X, and P2Y receptors in cells with tumor progression. The results indicate that purinergic signaling depends on the receptor concentration and signaling molecules specific to each cell type, tissue, and tumor histology. The purinergic system may function as either a tumor-promoting agent or an antitumor factor, depending on the microenvironmental conditions and the concentrations of receptors and their respective activators. Notably, ATP emerges as the most significant extracellular signal, capable of being converted into other cellular stimulators pertinent to neoplasms, such as adenosine diphosphate, adenosine monophosphate, adenosine, and inosine. Consequently, a cascade of responses to these stimuli promotes tumor development, cell division, and metastasis. Purine nucleotides in central nervous system tumors are pivotal in cellular responses in glioblastoma multiforme, vestibular schwannoma, medulloblastoma, adenomas, gliomas, meningiomas, and pineal tumors. These findings hold the potential for developing novel therapeutic strategies and aiding in therapeutic management. Graphical Abstract
- 1 October 2024
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (3) , 429-446
Purines and purinergic receptors in primary tumors of the central nervous system
Purine nucleotides and nucleosides play critical roles in various pathological conditions, including tumor cell growth. Adenosine triphosphate (ATP) activates pro-tumor receptors, while adenosine (ADO) is a potent immunosuppressant and modulator of cell growth. This study aims to analyze the purinergic actions of ATP and its metabolites, associated enzymes, and P1 or P2 class receptors in primary central nervous system tumors. Additionally, we sought to correlate the levels of nucleosides and the density of P1, P2X, and P2Y receptors in cells with tumor progression. The results indicate that purinergic signaling depends on the receptor concentration and signaling molecules specific to each cell type, tissue, and tumor histology. The purinergic system may function as either a tumor-promoting agent or an antitumor factor, depending on the microenvironmental conditions and the concentrations of receptors and their respective activators. Notably, ATP emerges as the most significant extracellular signal, capable of being converted into other cellular stimulators pertinent to neoplasms, such as adenosine diphosphate, adenosine monophosphate, adenosine, and inosine. Consequently, a cascade of responses to these stimuli promotes tumor development, cell division, and metastasis. Purine nucleotides in central nervous system tumors are pivotal in cellular responses in glioblastoma multiforme, vestibular schwannoma, medulloblastoma, adenomas, gliomas, meningiomas, and pineal tumors. These findings hold the potential for developing novel therapeutic strategies and aiding in therapeutic management. Graphical Abstract